HomeInsightsMarket Capitalization

Market Capitalization of Dr Reddys Laboratories Ltd

Market Capitalization of Dr Reddys Laboratories Ltd

stocks purchased

₹ 7.8 Cr

Volume Transacted

(Nov 21, 2024)

stocks purchased

64.9 K

Stocks Traded

(Nov 21, 2024)

Last Updated on: Nov 22, 2024

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Market Cap

₹ 99671.43 crore

Last updated on: Nov 21, 2024

Key Highlights

  • The Market Cap of Dr Reddys Laboratories Ltd is ₹ 99671 crore as of 21 Nov 24 .
  • The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 46069 crore on March 2019 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.29% over 6 years.
  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1194 as of 21 Nov 15:30 .
  • The Dividend Payouts of Dr Reddys Laboratories Ltd changed from ₹ 20 on Jul 15, 2019 to ₹ 40 on Jul 16, 2024 . This represents a CAGR of 12.25% over 6 years.

Historical Market Cap of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Company Fundamentals for Dr Reddys Laboratories Ltd

No data available

Image

Dr Reddys Laboratories Ltd

NSE: DRREDDY

Share Price

₹ 1194.55

-19.40 (-1.60%)

stock direction

Last updated on: Nov 21, 2024

Market Price of Dr Reddys Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20241194.55
19 Nov 20241213.95
18 Nov 20241193.35
14 Nov 20241226.05
13 Nov 20241245.7
12 Nov 20241263.1
11 Nov 20241288.2
08 Nov 20241281.85
07 Nov 20241287.15
06 Nov 20241303

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Dr Reddys Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Dr Reddys Laboratories Ltd

No data available

No data available

Historical P/E Ratio of Dr Reddys Laboratories Ltd

No data available

* All values are in %

Historical Revenue of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Dr Reddys Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Dr Reddys Laboratories Ltd

No data available

* All values are in

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Ltd (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories was incorporated in the year 1984 in Hyderabad.

Dr Reddys Laboratories Ltd News Hub

News

DRL slips after Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

21 Nov 202410:23

News

DRL's Hyderabad facility gets 7 observations from USFDA

The GMP inspection was conducted from 13 November 2024 to 19 November 2024. The USFDA issu...

Read more

20 Nov 202410:40

News

Mexican health regulator imposes penalty on Dr Reddy's

Dr Reddys Laboratories has received an order dated 12 November 2024, from COFEPRIS (Comisi...

Read more

14 Nov 202409:22

News

Dr Reddys Laboratories Ltd spurts 2.25%

Dr Reddys Laboratories Ltd is up for a third straight session in a row. The stock is quoti...

Read more

06 Nov 202413:05

News

Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore

Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% YoY, primari...

Read more

05 Nov 202417:35

News

Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel

Aurigene Oncology, a wholly-owned subsidiary of Dr. Reddy's Laboratories has announced the...

Read more

08 Oct 202418:16

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Dr Reddys Laboratories Ltd Market Cap

What is the market cap of Dr Reddys Laboratories Ltd?

As of November 22, 2024, Dr Reddys Laboratories Ltd has a market capitalization of ₹99671.43, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Dr Reddys Laboratories Ltd's market capitalization?

Dr Reddys Laboratories Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Dr Reddys Laboratories Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Dr Reddys Laboratories Ltd's market capitalization change?

Dr Reddys Laboratories Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*